Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection

•  Introduction •  Acute T. cruzi infection induces accentuated mobilization/migration of monocytic lineage cells into heart •  Heart inflammatory macrophages show a distinct morphology and are actively involved in parasite phagocytosis •  Lipid bodies as structural markers of inflammatory macrophages •  Macrophages and the resolution of acute inflammation and heart repair •  Concluding remarksAbstract The heart is the main target organ of the parasite Trypanosoma cruzi , the causal agent of Chagas' disease, a significant public health issue and still a major cause of morbidity and mortality in Latin America. During the acute disease, tissue damage in the heart is related to the intense myocardium parasitism. To control parasite multiplication, cells of the monocytic lineage are highly mobilized. In response to inflammatory and immune stimulation, an intense migration and extravasation of monocytes occurs from the bloodstream into heart. Monocyte differentiation leads to the formation of tissue phagocytosing macrophages, which are strongly activated and direct host defence. Newly elicited monocyte‐derived macrophages both undergo profound physiological changes and display morphological heterogeneity that greatly differs from originally non‐inflammatory macrophages, and underlie their functional activities as potent inflammatory cells. Thus, activated macrophages play a critical role in the outcome of parasite infection. This review covers functional and ultrastructural aspects of heart inflammatory macrophages triggered by the acute Chagas' disease, including recent discoveries on morphologically distinct, inflammation‐related organelles, termed lipid bodies, which are actively formed in vivo within macrophages in response to T. cruzi infection. These findings are defining a broader role for lipid bodies as key markers of macrophage activation during innate immune responses to infectious diseases and attractive targets for novel anti‐inflammatory therapies. Modulation of macrophage activation may be central in providing therapeutic benefits for Chagas' disease control.